TrialJournal of medicine and life2023

Add-on treatment with Cerebrolysin improves clinical symptoms in patients with ALS: results from a prospective, single-center, placebo-controlled, randomized, double-blind, phase II study.

Alfredo José Firstenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.